| Literature DB >> 31999762 |
Toshiharu Sasaki1,2,3, Sohei Harada1,3, Shungo Yamamoto4,5, Daisuke Ohkushi3, Brian Hayama3, Koichi Takeda3, Kosuke Hoashi3, Joji Shiotani6, Kazumi Takehana6, Yohei Doi1,2,7.
Abstract
PURPOSE: Previous studies have suggested that peripheral venous catheter is a significant source of gram-negative bacteraemia in patients with malignancy. We aimed to identify risk factors and develop a clinical prediction rule for the involvement of gram-negative organisms in peripheral venous catheter-associated bloodstream infections (PVC-BSIs) among patients with malignancy.Entities:
Year: 2020 PMID: 31999762 PMCID: PMC6992193 DOI: 10.1371/journal.pone.0228396
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of patients included in the study.
PVC, peripheral intravenous catheter.
Causative organism of peripheral intravenous catheter-associated bloodstream infections.
| Bacterial species recovered from blood cultures | No. of patients (%) |
|---|---|
| Gram-negative organisms | 60 (60.1) |
| | 8 (8.1) |
| | 6 (6.1) |
| | 7 (7.1) |
| | 6 (6.1) |
| | 6 (6.1) |
| | 5 (5.1) |
| | 5 (5.1) |
| | 3 (3.0) |
| | 3 (3.0) |
| | 3 (3.0) |
| | 2 (2.0) |
| | 1 (1.0) |
| | 1 (1.0) |
| | 1 (1.0) |
| | 1 (1.0) |
| | 1 (1.0) |
| | 1 (1.0) |
| Non-gram-negative organisms | 39 (39.4) |
| | 12 (12.1) |
| | 11 (11.1) |
| | 9 (9.1) |
| | 3 (3.0) |
| | 2 (2.0) |
| | 1 (1.0) |
| | 1 (1.0) |
Clinical characteristics of the patients with peripheral intravenous catheter-associated bloodstream infections.
| Covariate | Full cohort | Gram-negative infections | Non-gram-negative infections |
|---|---|---|---|
| Age, median [IQR] | 67.00 [59.00, 74.00] | 67.00 [60.00, 74.00] | 65.00 [56.50, 73.00] |
| Age ≥65 years | 59 (59.6) | 39 (65.0) | 20 (51.3) |
| Male sex | 73 (73.7) | 46 (76.7) | 27 (69.2) |
| Certainty of diagnosis | |||
| Definite | 4 (4.0) | 3 (5.0) | 1 (2.6) |
| Probable | 76 (76.8) | 51 (85.0) | 25 (64.1) |
| Possible | 19 (19.2) | 6 (10.0) | 13 (33.3) |
| Charlson comorbidity index, median [IQR] | 3.00 [2.00, 6.00] | 3.00 [2.00, 5.25] | 4.00 [2.00, 6.00] |
| Types of malignancy | |||
| Hematogical malignancy | 3 (3.0) | 1 (1.7) | 2 (5.1) |
| Solid tumor | 96 (97) | 59 (98.3) | 37 (94.9) |
| Neutropenia | 2 (2.0) | 0 (0.0) | 2 (5.1) |
| Showering within the week of index blood culture | 32 (32.3) | 23 (38.3) | 9 (23.1) |
| Duration of catherization, median days [IQR] | 5.00 [4.00, 7.00] | 5.00 [4.00, 7.00] | 5.00 [4.00, 7.00] |
| Placement for ≥4 days | 80 (80.8) | 46 (76.7) | 34 (87.2) |
| Infusate from peripheral intravenous catheter | |||
| ≥500 mL of fluid | 92 (92.9) | 57 (95.0) | 35 (89.7) |
| Intravenous fat emulsion | 16 (16.2) | 10 (16.7) | 6 (15.4) |
| Peripheral parenteral nutrition with amino acids | 70 (70.7) | 39 (65.0) | 31 (79.5) |
| Local phlebitis | 81(81.8) | 55 (91.7) | 26 (66.7) |
| Implementation of peripheral venous ultrasound | 11 (11.3) | 9 (15.3) | 2 (5.3) |
| Septic thrombophlebitis (Definite) | 2 (2.0) | 2 (3.3) | 0 (0) |
| Septic thrombophlebitis (Possible) | 8 (8.1) | 6 (10) | 2 (5.0) |
| Complications of catheter-associated bloodstrem infections | |||
| Infective endocarditis | 1 (1.0) | 1 (1.7) | 0 (0) |
| Local cellulitis or subcutaneous abscess | 5 (5.1) | 2 (3.3) | 3 (7.7) |
| Pitt bacteremia score, median [IQR] | 1.00 [0.00, 3.00] | 2.00 [1.00, 3.00] | 0.00 [0.00, 1.00] |
| Pitt bacteremia score ≥2 | 45 (45.5) | 37 (61.7) | 8 (20.5) |
| Duration of fever, median days [IQR] | 2.00 [1.00, 4.00] | 2.00 [1.00, 4.00] | 2.00 [1.25, 6.75] |
| Implementation of follow-up blood cultures | 51 (51.5) | 25 (41.7) | 26 (66.7) |
| Persistent bacteremia | 14 (14.1) | 7 (11.7) | 7 (17.9) |
| Duration of appropriate antimicrobial treatment, median days [IQR] | 15.00 [13.00, 21.00] | 15.00 [13.00, 20.75] | 16.00 [10.50, 21.50] |
| Duration of oral treatment, median days [IQR] | 0 [0, 10] | 5 [0, 10.25] | 0 [0, 8] |
| Duration between index blood culture and initiation of appropriate treatment, median days [IQR] | 0.00 [0.00, 1.00] | 0.00 [0.00, 1.00] | 1.00 [0.00, 2.00] |
| 30-day crude mortality | 9 (9.1) | 5 (8.3) | 4 (10.3) |
IQR, interquartile range.
Data are No. (%) of patients unless otherwise indicated.
Univariate and multivariate analysis of risk factors for peripheral intravenous catheter-associated gram-negative bloodstream infections.
| Variables | Unadjusted odds ratio | Adjusted odds ratio |
|---|---|---|
| Age ≥65 years | 1.76 (0.78–4.01) | 3.07 (1.10–8.62) |
| Peripheral parenteral nutrition with amino acids | 0.48 (0.19–1.23) | 0.31 (0.10–0.98) |
| Showering within the week of index blood culture | 2.07 (0.48–5.14) | 3.15 (1.07–9.26) |
| Placement of the catheter for ≥4 days | 0.48 (0.16–1.47) | 0.38 (0.11–1.36) |
| Pitt bacteremia score ≥2 | 6.23 (2.45–15.90) | 6.96 (2.52–19.2) |
CI, confidence interval.
PVC-GN scores.
| Variables | Score |
|---|---|
| Age ≥65 years | 1 |
| Peripheral parenteral nutrition with amino acids | −1 |
| Showering within the week of index blood culture | 1 |
| Pitt bacteremia score ≥2 | 2 |
The observed frequency and the predicted probability of PVC-associated gram-negative bloodstream infection for each cutoff point.
| Point | Observed frequency, % | Predicted probability, % |
|---|---|---|
| −1 | 11.1 (1/9) | 18.0 (7.9–35.9) |
| 0 | 44.4 (12/27) | 37.3 (24.8–51.7) |
| 1 | 58.3 (14/24) | 61.6 (50.1–72.0) |
| 2 | 73.9 (17/23) | 82.3 (68.2–89.8) |
| 3 | 100 (14/14) | 92.1 (79.9–97.2) |
| 4 | 100 (2/2) | 96.9 (87.6–99.3) |
CI, confidence interval.
Fig 2Calibration plots of (a) the original predivtive rule and (b) PVC-GN scoring system.
The dashed lines reflect perfect calibration between the ovserved frequency and predictive probability as reference. The long-dashed lines depict smooth nonparametric fits using locally weighted scatter plots for smoothing (Lowess).